Stay updated with breaking news from Yield10 Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Yield10 Bioscience says it has exercised its option to finalize a global, commercial license to advanced omega-3 production technology from UK based Rothamsted Research.
Yield10 Bioscience, Inc. (NASDAQ:YTEN – Get Free Report) was the target of a significant drop in short interest in September. As of September 30th, there was short interest totalling 131,300 shares, a drop of 26.6% from the September 15th total of 178,900 shares. Based on an average daily trading volume, of 332,800 shares, the days-to-cover […]
Yield10 Bioscience, Inc. (NASDAQ:YTEN – Get Free Report) major shareholder Jack W. Schuler acquired 765,000 shares of the firm’s stock in a transaction on Tuesday, August 15th. The stock was bought at an average price of $0.65 per share, with a total value of $497,250.00. Following the completion of the acquisition, the insider now directly […]
Yield10 Bioscience (NASDAQ:YTEN – Get Free Report) and YaSheng Group (OTCMKTS:HERB – Get Free Report) are both small-cap consumer staples companies, but which is the better stock? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, valuation, analyst recommendations and dividends. Profitability This table compares Yield10 Bioscience […]
WOBURN, Mass., Sept. 07, 2023 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN) (“Yield10” or the “Company”), an agricultural bioscience...